Non Executive Director - Chair Compensation Committee @ (February 2021 - Present)
Chief Executive Officer and CBO @ Curevac Us (June 2018 - March 2020)
Chief Business Officer @ Bamboo Therapeutics (February 2015 - January 2016)
Chief Business Officer @ (September 2013 - January 2015)
Board Member @ Paloma Pharmaceuticals (August 2013 - April 2014)
Chief Business Officer @ Zyngenia (November 2011 - May 2013)
Senior Vice President Corporate Business Development and Strategy @ Talecris Biotherapeutics, Inc. (October 2007 - September 2011)
Vice President Corporate Development, Strategy and Alliance Management @ (January 2002 - January 2007)
President Morphosys Usa and Senior Vice President Corporate Development @ (January 2000 - January 2002)
Vice President Business Development @ (January 1998 - January 1999)
National Accounts Leader @ Astra (January 1996 - January 1998)
Business Unit Manager @ Astra (January 1992 - January 1996)
Daniel Menichella Education
Unc Kenan - Flagler Business School
Master of Business Administration
1988-1990
Harvard University
Bachelor of Arts (Economics)
1977-1981
Daniel Menichella Summary
Daniel Menichella, based in United States, is currently a Chief Executive Officer at Kaleido Biosciences. Daniel Menichella brings experience from previous roles at Spybiotech, Curevac Us, Bamboo Therapeutics and Agtc. Daniel Menichella holds a 1988 - 1990 Master of Business Administration @ Unc Kenan - Flagler Business School. Daniel Menichella has 1 emails on RocketReach.
Looking for a different Daniel Menichella?
Find contact details for 700 million professionals.